Find clinical trials for Triple Negative Breast Cancer in Cincinnati, OH
CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones
Related conditions:
Triple Negative Breast Cancer trials near Cincinnati, OH, USA:
or pembrolizumab plus capecitabine in participants with triple negative breast cancer that still remains after su...
Phase 3
Cincinnati, Ohio, United States and 224 other locations
monotherapy versus olaparib in combination with an inhibitor of WEE1 (adavosertib \[AZD1775\]) in second or third line setting in patients with Triple...
Phase 2
Cincinnati, Ohio, United States and 140 other locations
to treatment of physician's choice (TPC) in participants with triple-negative breast cancer (TNBC) who received n...
Phase 3
Edgewood, Kentucky, United States and 247 other locations
III Study of Capivasertib + Paclitaxel versus Placebo + Paclitaxel as First line Treatment for Patients with Locally Advanced or Metastatic Triple...
Phase 3
Cincinnati, Ohio, United States and 258 other locations
This is a Phase III, randomised, open-label, 3-arm, multicentre, international study assessing the efficacy and safety of Dato-DXd with or without du...
Phase 3
Cincinnati, Ohio, United States and 306 other locations
including metastatic colorectal cancer (mCRC) patients....
Phase 1
Cincinnati, Ohio, United States and 38 other locations
farletuzumab ecteribulin (MORAb-202) in participants with selected tumor types (ovarian cancer \[OC\], endometrial cancer -...
Phase 1, Phase 2
Cincinnati, Ohio, United States and 58 other locations
pharmacokinetics (PK), pharmacodynamics (PD), and preliminary anti-tumor activity of JANX008 in adult subjects with advanced or metastatic c...
Phase 1
Cincinnati, Ohio, United States and 17 other locations
This is a first-in-human phase I/II study to examine the safety, tolerability and preliminary efficacy of VLS-1488 in subjects with advanced cancers...
Phase 1, Phase 2
Cincinnati, Ohio, United States and 12 other locations
of tumor and/or stromal area of infiltrating lymphocytes prior to initiation of standard neoadjuvant chemotherapy. At enrollment, patients ...
Phase 2
Edgewood, Kentucky, United States and 3 other locations
Clinical trials
Research sites
Resources
Legal